1. A pharmacokinetics (PK) bioequivalence trial of proposed trastuzumab biosimilar, Myl-1401O (A) vs EU-Herceptin (B) and US-Herceptin (C). (February 2017) Authors: Waller, C.; Vutikullird, A.; Lawrence, T.; Shaw, A.; Liu, M.S.; Baczkowski, M.; Sharma, R.; Barve, A.; Pennella, E. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A pharmacokinetics and pharmacodynamics equivalence trial of proposed pegfilgrastim biosimilar, MYL-1401H vs EU-Neulasta® and US-Neulasta®. (February 2017) Authors: Waller, C.; Tiessen, R.; Lawrence, T.; Shaw, A.; Liu, M.; Sharma, R.; Baczkowski, M.; Kothekar, M.; Dias, R.; Barve, A.; Pennella, E. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia. (February 2017) Authors: Waller, C.; Blakeley, C.; Pennella, E.; Bronchud, M.H.; Mattano, L.; Berzoy, O.; Voitko, N.; Adamchuk, H.; Zautashvili, Z.; Vinnyk, Y.; Nemsadze, G.; Dzagnidze, G.; Shparyk, Y.; Lytvyn, I.; Rusyn, A.; Popov, V.; Láng, I.; Sharma, R.; Baczkowski, M.; Kothekar, M. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗